Semiconductor & Technology Specialist, Ingenuity

William Keating

Dr. William Keating is a highly experienced senior executive with over 25 years experience in the IT/Semiconductor Industry. The majority of Dr. Keating's career was spent at Intel Corporation where he held senior leadership positions in Europe, the US and Asia from 1992 through 2014. He served as Intel's IT Director for APAC, China & Japan from 2005 through 2014 when he was based in Hong Kong and was responsible for the IT systems (Infrastructure, Networks, Data Centres, ERP, Sales & Marketing systems, Business Intelligence etc. ) for all of Intel's offices & factories through the region. From 1998 through 2005, he was the founder & director of an internal IT Consulting Organisation (IT Flex Services), a 500-person team which remains a core part of the Intel IT Organisation to this day. Dr. Keating's first 6 years at Intel were spent in charge of the Factory Automation Systems (Robotics, Databases, Networks, Servers, Clients etc.) supporting Intel's then state-of-the-art 200mm factory network. Since leaving Intel in 2014, Dr Keating established his own Technology Research & Consulting Company (www.ingenuity.hk) where he focuses on the products, roadmaps & technologies of companies such as Intel, AMD, Samsung, Apple, Micron- as well as the key equipment suppliers to those companies e.g. ASML, AMAT, Canon, Nikon etc. Dr. Keating specializes in niche topics of high significance within the semiconductor industry. These include the future of Moore's Law and in particular the significance of Lithography in maintaining Moore's Law (EUV, SDA, NanoImprint), the role & growth of the GPU in specialised applications such as Deep Learning (Neural Networks) for Voice, Image & Pattern recognition at companies such as Facebook, Google & Baidu. He also holds regular discussions on the future of memory, in particular the rise of 3D NAND and the emergence of new memory technologies such as 3D Xpoint.

Semiconductor & Technology Specialist

COVID-19: An Alternative Data Approach To Analysing China's Return To Work Status

COVID-19 Alternative Data China Impact Assessment Update #1

Ingenuity

Our focus is exclusively on in-depth research & consulting in the broader semiconductor industry. We focus on the key players, namely Intel, Micron, Qualcomm, Apple, Samsung, NVIDIA, AMD, TSMC & Global Foundries - as well as some of the lesser known, but nonetheless critical, companies such as ASML (for EUV), Mellanox, Cavium, Xilinx etc. We specialise in their products, roadmaps, process technologies, competitive advantages & threats etc. We also help our clients understand the implications of new and emerging technologies, e.g. 3D X-Point, 3D NAND, Carbon Nanotubes, Autonomous Driving, Graphene, Silicon Photonics, Wafer-Level Optics, Artificial Intelligence, FPGA, GPU, ASIC etc. 

Semiconductor Analysis & Research

Thematic (Sector/Industry)

Macau Semiconductors and semiconductor equipment / Thematic (Sector/Industry)

<p>South Korea's COVID-19 case fatality rate (CFR) is currently 0.72%, more than five times lower than China's CFR of 3.86% according to the latest <a href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19.pdf?sfvrsn=70dabe61_4" target="_blank" rel="noopener">data</a> published by the World Health Organisation (WHO). We think that South Korea's CFR will be found to be indicative of the final, global CFR once this pandemic has passed, and explain why.</p><p>While a lower CFR is clearly a good thing, it does raise an interesting dilemma, particularly for two countries with relatively large numbers of deaths, namely Italy and Iran. If 0.72% is the actual CFR, it means that the numbers of people already infected in those countries is already far higher than the reported numbers. We explain why. </p>

South Korea's COVID-19 case fatality rate (CFR) is currently 0.72%, more than five times lower than China's CFR of 3.86% according to the latest data published by the World Health Organisation (WHO). We think that South Korea's CFR will be found to be indicative of the final, global CFR once this pandemic has passed, and explain why.While a lower CFR is clearly a good thing, it does raise an interesting dilemma, particularly for two countries with relatively large numbers of deaths, namely Italy and Iran. If 0.72% is the actual CFR, it means that the numbers of people already infected in those countries is already far higher than the reported numbers. We explain why. 

COVID-19. South Korea's Mortality Rate & Its Implications For Italy & Iran